vs
Side-by-side financial comparison of Anteris Technologies Global Corp. (AVR) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $310.0K, roughly 1.4× Anteris Technologies Global Corp.). SenesTech, Inc. runs the higher net margin — -428.5% vs -9420.0%, a 8991.5% gap on every dollar of revenue. SenesTech, Inc. produced more free cash flow last quarter ($-1.7M vs $-18.9M).
Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
AVR vs SNES — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $310.0K | $421.0K |
| Net Profit | $-29.2M | $-1.8M |
| Gross Margin | 70.6% | 55.3% |
| Operating Margin | -9343.5% | -446.8% |
| Net Margin | -9420.0% | -428.5% |
| Revenue YoY | — | -16.0% |
| Net Profit YoY | — | -43.7% |
| EPS (diluted) | $-0.74 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $310.0K | $421.0K | ||
| Q3 25 | $429.0K | $690.0K | ||
| Q2 25 | $618.0K | $625.0K | ||
| Q1 25 | $556.0K | $485.0K | ||
| Q4 24 | — | $501.0K | ||
| Q3 24 | — | $482.0K | ||
| Q2 24 | — | $459.0K | ||
| Q1 24 | — | $415.0K |
| Q4 25 | $-29.2M | $-1.8M | ||
| Q3 25 | $-22.2M | $-1.3M | ||
| Q2 25 | $-20.8M | $-1.6M | ||
| Q1 25 | $-21.9M | $-1.7M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | 70.6% | 55.3% | ||
| Q3 25 | 71.3% | 62.8% | ||
| Q2 25 | 76.1% | 65.4% | ||
| Q1 25 | 62.8% | 64.5% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | 65.4% | ||
| Q2 24 | — | 54.2% | ||
| Q1 24 | — | 32.5% |
| Q4 25 | -9343.5% | -446.8% | ||
| Q3 25 | -5190.0% | -195.2% | ||
| Q2 25 | -3379.3% | -258.2% | ||
| Q1 25 | -3917.3% | -342.9% | ||
| Q4 24 | — | -250.9% | ||
| Q3 24 | — | -321.0% | ||
| Q2 24 | — | -349.0% | ||
| Q1 24 | — | -444.1% |
| Q4 25 | -9420.0% | -428.5% | ||
| Q3 25 | -5185.1% | -188.1% | ||
| Q2 25 | -3371.2% | -258.6% | ||
| Q1 25 | -3932.4% | -343.3% | ||
| Q4 24 | — | -250.5% | ||
| Q3 24 | — | -313.9% | ||
| Q2 24 | — | -345.1% | ||
| Q1 24 | — | -441.4% |
| Q4 25 | $-0.74 | $0.48 | ||
| Q3 25 | $-0.62 | $-0.28 | ||
| Q2 25 | $-0.58 | $-0.87 | ||
| Q1 25 | $-0.61 | $-1.28 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-2.07 | ||
| Q2 24 | — | $-3.08 | ||
| Q1 24 | — | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.6M |
| Total DebtLower is stronger | $22.0K | — |
| Stockholders' EquityBook value | $-93.0K | $9.6M |
| Total Assets | $23.0M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | $49.0M | $1.7M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-93.0K | $9.6M | ||
| Q3 25 | $3.7M | $11.3M | ||
| Q2 25 | $24.4M | $7.0M | ||
| Q1 25 | $43.3M | $2.9M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $3.7M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $4.6M |
| Q4 25 | $23.0M | $12.8M | ||
| Q3 25 | $19.1M | $14.6M | ||
| Q2 25 | $39.9M | $10.4M | ||
| Q1 25 | $58.8M | $3.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | — | $5.5M |
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.5M | $-1.7M |
| Free Cash FlowOCF − Capex | $-18.9M | $-1.7M |
| FCF MarginFCF / Revenue | -6104.5% | -398.3% |
| Capex IntensityCapex / Revenue | 128.1% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-79.8M | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.5M | $-1.7M | ||
| Q3 25 | $-18.3M | $-1.4M | ||
| Q2 25 | $-19.5M | $-1.1M | ||
| Q1 25 | $-21.5M | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | $-18.9M | $-1.7M | ||
| Q3 25 | $-19.0M | $-1.4M | ||
| Q2 25 | $-20.1M | $-1.2M | ||
| Q1 25 | $-21.7M | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | -6104.5% | -398.3% | ||
| Q3 25 | -4434.5% | -205.9% | ||
| Q2 25 | -3247.9% | -191.5% | ||
| Q1 25 | -3909.5% | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | — | -354.2% | ||
| Q1 24 | — | -441.2% |
| Q4 25 | 128.1% | 3.1% | ||
| Q3 25 | 180.0% | 6.1% | ||
| Q2 25 | 86.9% | 7.5% | ||
| Q1 25 | 44.6% | 7.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
